Investor Presentation
Solid Financial Profile
Gerresheimer at a Glance
Plastics & Devices
(P&D)
Revenues 2019
EUR 758.3m
Adj. EBITDA 2019
EUR 196.4m
Contract Design Manufacturing
Medical Devices (incl. tooling)
Primary Packaging Plastics
Prescription Business
(Centor, US)
Syringes Systems
13.10.2020
Investor Presentation
Gerresheimer Group
(incl. headquarters)
Revenues 2019
EUR 1.40bn
Adj. EBITDA 2019
EUR 297m
Leverage at 3.2x
as of May 31, 2020
Primary Packaging Glass
(PPG)
Revenues 2019
EUR 631.6m
Adj. EBITDA 2019
EUR 122.9m
GERRESHEIMER
Advanced Technologies
(GAT)
Revenues 2019
EUR 6.4m
Adj. EBITDA 2019
EUR -23.4m
Moulded Glass Pharma
Moulded Glass Cosmetics
(incl. Beverages)
Tubular Glass Pharma
(Converting)
Dedicated to developing and
producing intelligent drug delivery
systems and value added devices
Technology & Platform Operator
Own R&D capabilities
5View entire presentation